⌘K

Login Start Free

Home/Filings/4/0000950170-24-061597

4//SEC Filing

Byrnes Michael 4

Accession 0000950170-24-061597

CIK 0001828522other

View on SEC.gov Company Profile

Filed

May 16, 8:00 PM ET

Accepted

May 17, 4:00 PM ET

Size

4.7 KB

Accession

0000950170-24-061597

Insider Transaction Report

Form 4

Period: 2024-05-15

eFFECTOR Therapeutics, Inc.EFTR

Chief Financial Officer

Transactions

Award
Common Stock
2024-05-15$1.68/sh+1,387$2,334→ 3,117 total

Footnotes (1)

[F1]These shares were acquired under the eFFECTOR Therapeutics, Inc. 2021 Employee Stock Purchase Plan.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

eFFECTOR Therapeutics, Inc.

CIK 0001828522

Entity typeother

Related Parties

1

filerCIK 0001619893

Filing Metadata

Form type: 4
Filed: May 16, 8:00 PM ET
Accepted: May 17, 4:00 PM ET
Size: 4.7 KB

View on SEC.gov